PharVision Advisers’s St. Joe Company JOE Stock Holding History

PharVision Advisers’s Portfolio JOE Stock Details JOE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,742	Closed	-$235K	–	853
2025 Q3	$235K	Buy	+4,742	New	+$239K	0.13%	379

Other funds holding JOE

FCM

Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return

PharVision Advisers's JOE Position: Q4 2025 in Review

PharVision Advisers sold out of St. Joe Company (JOE) in Q4 2025, closing a stake of 4,742 shares — an estimated $235K sold.

PharVision Advisers first reported a position in JOE in Q3 2025 and held it in 1 quarter. The position peaked at $235K in Q3 2025. 296 funds tracked by Wall St. Rank hold JOE as of Q4 2025.

PharVision Advisers reported no remaining St. Joe Company position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 4,742 St. Joe Company shares in Q4 2025, an estimated $235K.
PharVision Advisers first reported a position in St. Joe Company in Q3 2025 and held it in 1 quarter.
PharVision Advisers's St. Joe Company position peaked at $235K in Q3 2025.
296 funds tracked by Wall St. Rank held St. Joe Company as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.